An accurate biomarker is essentially significant for gastric cancer because it responds to solo immunotherapy infrequently. dMMR/MSI and EBV are helpful biomarkers but merely account for a small part of patients ( 11 ).
← all excerpts
A Signature-Based Classification of Gastric Cancer That Stratifies Tumor Immunity and Predicts Responses to PD-1 Inhibitors.
1
—
—